The extravascular implantable cardioverter–defibrillator (ICD) has a single lead implanted substernally to enable pause-prevention pacing, antitachycardia pacing, and defibrillation energy similar to ...
Cardiac implantable electronic devices (CIEDs) constitute a major breakthrough in the management of heart rhythm disorders. These devices largely include bradycardia pacemakers, biventricular ...
The indications for ICD implantation continue to expand; however, these devices are associated with complications related to the implantation procedure itself and morbidity caused by the normal and ...
Antitachycardia pacing (ATP) refers to the use of pacing stimulation techniques for termination of tachyarrhythmias. Such techniques can be automatically applied using implantable cardioverter ...
A major international trial found that subcutaneous implantable cardioverter-defibrillators (S-ICDs) can be implanted without routine defibrillation testing when guided by the PRAETORIAN score, ...
If you have hypertrophic cardiomyopathy (HCM), and especially if you have obstructive HCM that reduces blood flow out of your heart, you and your doctor may discuss ways to lower your risk of sudden ...
MedPage Today on MSN
Novel ICD lead for conduction system pacing enters the arena
First-in-human report for UltiSynq CSP ICD lead ...
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--AtaCor Medical, Inc. (“AtaCor”) announced today that it will present initial findings from its first-in-human extravascular implantable cardioverter ...
This section describes safety outcomes from the published literature that the committee considered as part of the evidence about this procedure. For more detailed information on the evidence, see the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results